Novartis

Multinational biopharmaceutical company

Based in DC

🤖

AI Overview

With $1.8M in lobbying spend across 30 quarterly filings, Novartis is a significant lobbying presence. They deploy 23 individual lobbyists

$1.8M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
23
Individual Lobbyists

Spending by Year

YearLobbying Spend
2019$220K
2020$270K
2021$280K
2022$200K
2023$240K
2024$300K
2025$300K

Lobbying Firms

BROWNSTEIN HYATT FARBER SCHRECK, LLP

What They Lobby For

  • Issues related to cell and gene therapy, development of therapies for rare diseases, pharmaceutical pricing; Issues related to corporate environmental sustainability
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases
  • Issues related to corporate environmental sustainability
  • Tax filing programs
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases H.R. 748 CARES Act, Issues related to COVID-19 treatment
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases Issues related to COVID-19
  • Opportunities for health care collaboration
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19 treatment H.R.1319 - American Rescue Plan Act of 2021
  • Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases, Issues related to COVID-19 treatment

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.